Characteristics of type 2 diabetic patients cared for by general practioners either with medical nutrition therapy alone or with hypoglycaemic drugs

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 17, Issue 2, 2004, Pages 120-123

  Ciardullo, Anna V ^a   Brunetti, M ^a   Daghio, M M ^a   Bevini, M ^b   Feltri, G ^b   Novi, D ^b   Di Nardo, A ^a   Menna, A ^a   Magrini, N ^a  

^a Ctr Eval Effectiveness Hlth Care   (Italy)

^b Local Health Unit   (Italy)

Author keywords

Diabetes mellitus; Diet therapy; Diseases Management; Family practice; Health services research

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIABETIC FOOT; DIABETIC RETINOPATHY; DIET THERAPY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENERAL PRACTITIONER; HEART FAILURE; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

AGE FACTORS; AGED; ALBUMINURIA; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FAMILY PRACTICE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; NUTRITION PHYSIOLOGY; TIME FACTORS; TRIGLYCERIDES;

EID: 2942528740     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Pan X.R., Li G.W., Hu Y.H., Wang J.X., Yang W.Y., An Z.X, Hu Z.X., Lin J., Xiao J.Z., Cao H.B., Liu P.A., Jiang Y.G., Jiang Y.Y., Wang J.P., Zheng H., Zhang H., Bennet P.H., Howard B.V.: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20: 537-544, 1997.
2. Riccardi G., Rivellese A.A.: Diabetes: nutrition in prevention and management. Nutr. Metab. Cardiovasc. Dis. 9: 33-36, 1999
3. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., Nathan D.M.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346: 393-403, 2002
4. American Diabetes Association. Clinical Practice Recommendations 2003. Diabetes Care 26: S1-156, 2003
5. Greenhalgh P.M.: Shared care for diabetes: a systematic review. RCGP Occasional Paper 67. Royal College of General Practitioners, London, 1994
6. Medea G., Lonati F.: Disease management del diabete mellito tipo 2. II Progetto Brescia. Parte II. S.I.M.G. 8-10: 24-28, 2002.
7. United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. B.M.J. 310: 83-88, 1995.
8. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared to conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998.
9. DAI Study Group: The DAI prospective study on macrovascular complications in patients with type 2 diabetes. Characteristics of the study population. Ann. Ist. Super. Sanità 37: 289-296, 2001